Systematic review: Pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 6, 2006, Pages 691-712

  Sallam, H ^a   McNearney, T A ^a   Chen, J D Z ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIDIARRHEAL AGENT; BETHANECHOL; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CISAPRIDE; DOMPERIDONE; DOXYCYCLINE; ERYTHROMYCIN; ESOMEPRAZOLE; LAXATIVE; METOCLOPRAMIDE; METRONIDAZOLE; NEOSTIGMINE METHYL SULFATE; NORFLOXACIN; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; PRUCALOPRIDE; RABEPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR; TEGASEROD; TETRACYCLINE;

ACUPUNCTURE; BACTERIAL OVERGROWTH; BRADYCARDIA; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; COLON MOTILITY; CONSTIPATION; DIARRHEA; DIET THERAPY; DRUG EFFICACY; ELECTROACUPUNCTURE; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MOTILITY; FOLLOW UP; GASTRIC DYSMOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY DISORDER; HEART ARREST; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE PERFORATION; LIFESTYLE; MALABSORPTION; MEDLINE; MYOELECTRICITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; STOMACH ANTRUM RESECTION; STOMACH EMPTYING; STOMACH FUNDOPLICATION; STOMACH PARESIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; TOTAL PARENTERAL NUTRITION; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUBE FEEDING; UNSPECIFIED SIDE EFFECT;

COLON; ESOPHAGEAL DISEASES; ESOPHAGUS; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; LIFE STYLE; PROTON PUMPS; SCLERODERMA, SYSTEMIC; STOMACH; STOMACH DISEASES;

EID: 33644745118     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02804.x     Document Type: Review

References (204)

1. Mayes MD Scleroderma epidemiology Rheum Dis Clin North Am 2003 29 239 54
2. Cohen S The gastrointestinal manifestations of scleroderma: pathogenesis Gastroenterology 1980 79 155 66
3. Nasi A Pinotti H Repercussoes esofagiacas da esclerose sistemica progressive In Pinotti HW ed Tratado de clinica cirurgica de aparelho digestivo São Paulo, Brazil Atheneu 1995 310 5
4. Attar A Digestive manifestations in systemic sclerosis Ann Med Interne (Paris) 2002 153 260 4
5. Lock G Holstege A Lang B Schölmerich J Gastrointestinal manifestations of progressive systemic sclerosis Am J Gastroenterol 1997 92 763 71
6. Sridhar K Lange R Magyar L Soykan I McCallum R Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications J Lab Clin Med 1998 123 541 6
7. Weston S Thumshirn M Wiste J Carnilleri M Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders Am J Gastroenterol 1998 93 1085 9
8. Clements PJ Becvar R Drosos AA Ghattas L Gabrielli A Assessment of gastrointestinal involvement Clin Exp Rheumatol 2003 21 3 Suppl. 29 S15 8
9. Abu-Shakra M Guillemin F Lee P Gastrointestinal manifestations of systemic sclerosis Semin Arthritis Rheum 1994 24 29 39
10. Jiranek GC Bredfelt JE Organ involvement: gut and hepatic manifestations In Clements PJ Furst DE eds Systemic Sclerosis Baltimore, USA Williams and Wilkins 1996 453 81
11. Poirier TJ Rankin GB Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases Am J Gastroenterol 1972 58 30 44
12. Sjögren RW Gastrointestinal motility disorders in scleroderma Arthritis Rheum 1994 37 1265 82
13. Sjögren RW Gastrointestinal features of scleroderma Curr Opin Rheumatol 1996 8 569 75
14. Young MA Rose S Reynolds JC Gastrointestinal manifestations of scleroderma Rheum Dis Clin North Am 1996 22 797 823
15. Weihrauch TR Korting GW Manometric assessment of esophageal involvement in progressive systemic sclerosis, morphoca and Raynaud's disease Br J Dermatol 1982 107 325 32
16. Marie I Cailleux N Levesque H Watermelon stomach and progressive systemic sclerosis: localization of digestive system involvement Arthritis Rheum 1996 39 1439
17. Weber P Ganser G Frosch M et al. 24-h intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease J Rheumatol 2000 27 2692 5
18. Steen V Medsger T Severe organ involvement in systemic sclerosis with diffuse scleroderma Arthritis Rheum 2000 43 2437 44
19. Dantas RO Villanova MG de Godoy RA Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases Arq Gastroenterol 1985 22 122 6
20. Marie I Levesque H Ducrotte P et al. Manometry of the upper intestinal tract in patients with systemic sclerosis - a prospective study Arthritis Rheum 1998 41 1874 83
21. Greydanus MP Camirelli M Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis Gastroenterology 1989 96 110 5
22. Ponge T Bruley des Varannes S Digestive involvement of scleroderma Rev Prat 2002 52 1896 900
23. DiMarino AJ Carlson G Myers A et al. Duodenal myoelectric activity in scleroderma N Engl J Med 1973 289 1220 3
24. Lock G Straub RH Zeuner M et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis J Rheumatol 1998 25 1330 5
25. Iovino P Valentini G Ciacci C et al. Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function Dig Dis Sci 2001 46 723 30
26. Straub RH Zeuner M Lock G et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis J Rheumatol 1996 23 87 92
27. Sonnex C Paice E White AG Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients Ann Rheum Dis 1986 45 957 60
28. Dessein PH Joffe BI Metz RM Millar DL Lawson M Stanwix AE Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability Am J Med 1992 93 143 50
29. Generini S Fiori G Moggi Pignone A Matucci Cerinic M Cagnoni M Systemic sclerosis. A clinical overview Adv Exp Med Biol 1999 455 73 83
30. Franck-Larsson K Hedenstrom H Dahl R Ronnblom A Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity Scand J Rheumatol 2003 32 348 55
31. Malandrini A Selvi E Villanova M et al. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases J Rheumatol 2000 27 1203 6
32. Eaker EY Kuldau JG Verne GN Ross SO Sallustio JE Myenteric neuronal antibodies in scleroderma - passive transfer evokes alterations in intestinal myoelectric activity in a rat model J Lab Clin Med 1999 133 551 6
33. Wegener M Adamek RJ Wedmann B Jergas M Altmeyer P Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis Dig Dis Sci 1994 39 2209 15
34. Feussner H Kreis M Weiser HF Motility disorders of the esophagus in progressive systemic scleroderma. Pathophysiology, diagnosis and therapy Hautarzt 1988 39 291 7
35. Von Muhlen CA Anselmi OE Ludwig EB Cutin J Scintigraphic diagnosis of esophageal involvement in systemic sclerosis (scleroderma) Z Rheumatol 1989 48 167 74
36. Vidal Neira LF Piscoya Arbanil J Rolando Castaneda T Aita Arroyo G Frias Coronado V Garcia-Calderon JH Digestive involvement in progressive systemic sclerosis Arq Gastroenterol 1988 25 8 22
37. Marshall JB Kretschmar JM Gerhardt DC et al. Gastrointestinal manifestations of mixed connective tissue disease Gastroenterology 1990 98 5 Pt I 1232 8
38. Ipsen P Egekvist H Aksgiaede K Zachariae H Bjerring P Thommesen P Oesophageal manometry and video-radiology in patients with systemic sclerosis: a retrospective study of its clinical value Acta Derm Venereol 2000 80 130 3
39. Fulp SR Castell DO Scleroderma esophagus Dysphagia 1990 5 204 10
40. Bestetti A Carola F Conciato L Marasini B Tarolo GL Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon J Nucl Med 1999 40 77 84
41. Alvarez MG Rubaldo RE Kerzberg EM De Paula A Huberman ED Gastrointestinal involvement in progressive systemic sclerosis Acta Gastroenterol Latinoam 1984 14 295 302
42. Weihrauch TR Ewe K Weis H Korting GW Manometric study of esophageal involvement in progressive systemic sclerosis Arch Dermatol Res 1975 254 29 35
43. Turner R Lipshutz W Miller W et al. Esophageal dysfunction in collagen disease Am J Med Sci 1973 265 191
44. Akesson A Wollheim FA Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma Br J Rheumatol 1989 28 281
45. Villadsen GE Storkholm J Zachariae H Hendel L Bendtsen F Gregersen H Oesophageal pressure-cross-sectional area distributions and secondary peristalsis in relation to subclassification of systemic sclerosis Neurogastroenterol Motil 2001 13 199 210
46. Carola F Bianchi PA Basilisco G lntraesophageal pH monitoring during acid infusion in patients with systemic sclerosis Dig Dis Sci 1999 44 1716 20
47. Lock G Pfeifer M Straub RH et al. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis Am J Gastroenterol 1998 93 341 5
48. Villadsen GE Storkholm JH Hendel L Vilstrup H Gregersen H Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus Dig Dis Sci 1997 42 2317 26
49. Cameron AJ Malcolm A Prather CM Phillips SF Videoendoscopic diagnosis of esophageal motility disorders Gastrointest Endosc 1999 49 62 9
50. Yarze JC Varga J Stampfl D Castell DO Jimenez SA Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients Am J Gastroenterol 1993 88 870 6
51. Mearin F Fonollosa V Vilardell M Malagelada JR Mechanical properties of the gastro-esophageal junction in health, achalasia, and seleroderma Scand J Gastroenterol 2000 35 705 10
52. Corti RE Outeda JL Naveiro JJ Nicolino D Corti RN Crosefti E Clinico-manometric correlation in esophageal involvement of progressive systemic sclerosis Acta Gastroenterol Latinoam 1982 12 1 9
53. Henry M Harbermann M Rocha O Esophageal motor disturbances in progressive systemic sclerosis Dis Esophagus 1999 12 51 3
54. Park RH McKillop JH Belch JJ Faichney A MacKenzie JF Achalasia-like syndrome in systemic sclerosis Br J Surg 1990 77 46 9
55. Carette S Lacourciere Y Lavoie S Halle P Radionuclide esophageal transit in progressive systemic sclerosis J Rheumatol 1985 12 478 81
56. Zaninotto G Peserico A Constantini M et al. Oesophageal motility and lower esophageal sphincter competence in progressive systemic sclerosis and localized scleroderma Scand J Gastroeneterol 1989 24 95 102
57. Cozzi F Zucchefta P Durigon N et al. Changes in esophageal peristalsis in diverse clinical forms and antibody specificity in scleroderma - a scintigraphic study in 100 cases Reumatismo 2003 55 86 92
58. Maddern GJ Horowitz M Jamieson GG Chatterton BE Collins PJ Roberts-Thomson P Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis Gastroenterology 1984 87 922 6
59. Wang SJ Lan JL Chen DY et al. Solid-phase radionuclide esophageal transit in progressive systemic sclerosis Hepatogastroenterology 2002 49 989 91
60. Mariani G Boni G Barreca M et al. Radionuclide gastroesophageal motor studies J Nucl Med 2004 45 1004 28
61. Geatti O Shapiro B Fig LM et al. Radiolabelled semisolid test meal clearance in the evaluation of esophageal involvement in scleroderma and Sjogren's syndrome Am J Physiol Imaging 1991 6 65 73
62. Koshino Y Takai T Kato T et al. Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to the disease severity Gastroenterol Jpn 1991 26 575 81
63. Wojas-Pelc A Stepien A Lipko-Godlewska S Wielowieyska-Szybinska D Zabinska-Plazak E Kieltyka A Esophageal scintigraphy in patients with systemic sclerosis: clinical symptoms correlated with the esophagus noted by the patients Przegl Lek 2002 159 973 6
64. Dantas RO Aprile L Esophageal striated muscle contractions in patients with gastroesophageal reflux symptoms Dig Dis Sci 2002 47 2586 90
65. Kinuya K Nakajima K Kinuya S Michigishi T Tonami N Takehara K Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement Ann Nucl Med 2001 15 97 101
66. Bassotti G Battaglia E Debernardi V et al. Esophageal dysfunction in scleroderma: relationship with disease subsets Arthritis Rheum 1997 40 2252 9
67. De Castro Parga ML Alonso P Garcia Porrua C Prada JI Esophageal mucosal lesions and scleroderma - prevalence, symptoms and risk factors Rev Esp Enferm Dig 1996 88 93 8
68. Al-Amri SM The pattern of esophageal manometry in progressive systemic sclerosis Saudi Med J 2003 24 68 71
69. Murphy JR McNally P Peller P Shay SS Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis Dig Dis Sci 1992 37 833 41
70. Bortolotti M Turba E Tosti A et al. Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma Am J Gastroenterol 1991 86 743 7
71. Marie I Levesque H Ducrotte P et al. Gastric involvement in systemic sclerosis - a prospective study Am J Gastroenterol 2001 96 77 83
72. Rose S Young MA Reynolds JC Gastrointestinal manifestations of scleroderma Gastroenterol Clin North Am 1998 27 563 94
73. Zamost BJ Hirschberg J Ippoliti AF Furst DE Clements PJ Weinstein WM Esophagitis in scleroderma. Prevalence and risk factors Gastroenterology 1987 92 421 8
74. Foggi E Spaggiari L Carbognani P Rusca M Soliani P Dell'Abate P Functional study of the esophagus in progressive systemic sclerosis: utility of the manometry Acta Biomed Ateneo Parmense 1991 62 155 60
75. Katzka DA Reynolds JC Saul SH et al. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma Am J Med 1987 82 46 52
76. Marie I Dominique S Levesque H et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis Arthritis Rheum 2001 45 346 54
77. Herrick AL Development of agents for the treatment of systemic sclerosis Expert Opin Investig Drugs 2001 10 1255 64
78. Shoenut JP Wieler JA Micflikier AB The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole Aliment Pharmacol Ther 1993 7 509 13
79. Hendel L Hage E Hendel J Stentoft P Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis Aliment Pharmacol Ther 1992 6 565 77
80. Pope JE Treatment of systemic sclerosis Rheum Dis Clin North Am 1996 22 893 907
81. Johnson DA Drane WE Curran J et al. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities Arch Intern Med 1987 147 1597 601
82. Ramirez-Mata M Ibanez G Alarcon-Segovia D Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients of patients with PSS Arthritis Rheum 1977 20 30 4
83. Drane WE Karvelis K Johnson DA Curran JJ Silverman ED Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis J Nucl Med 1987 28 810 5
84. Wehrmann T Caspary WF Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma Klin Wochenschr 1990 68 602 7
85. Wang SJ La JL Chen DY et al. Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis Clin Rheumatol 2002 21 43 5
86. Denton C Black C Scleroderma - clinical and pathological advances Best Pract Res Clin Rheumatol 2004 18 271 90
87. Tonini M De Ponti F Di Nucci A et al. Cardiac adverse effects of gastrointestinal prokinetics Aliment Pharmacol Ther 1999 13 1585 91
88. Kahrilas P Quigley E Castell D Spechler S The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease Aliment Pharmacol Ther 2000 14 1503 9
89. Topart R Deschamps C Taillefer R Duranceau A Scleroderma and esophageal reflux, surgical monitoring Ann Chir 1992 46 794 9
90. Mittal BR Wanchu A Das BK Ghosh PP Sewatkar AB Misra RN Pattern of gastric emptying in patients with systemic sclerosis Clin Nucl Med 1996 21 379 82
91. Zuccaro G Jr. Esophagoscopy and endoscopic esophageal ultrasound in the assessment of esophageal function Semin Thorac Cardiovasc Surg 2001 13 226 33
92. Walter H Endoscopic Treatment of GERD: Promises and Pitfalls American Motility Society 12th Biennial Meeting, 19-22 September 2002 q6
93. Tonini M De Giorgio R De Ponti F Progress with novel pharmacological strategies for gastro-oesophageal reflux disease Drugs 2004 64 347 61
94. Maeda M Ichiki Y Sumi A Mori S A trial of acupuncture for progressive systemic sclerosis J Dermatol 1988 15 133 40
95. Kaada B Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration Scand J Gastroenterol 1987 22 1137 46
96. Mearin F Zacchi P Armengol JR Vilardell M Malagelada JR Effect of transcutaneous nerve stimulation on esophageal motility in patients with achalasia and scleroderma Scand J Gastroenterol 1990 25 1018 23
97. Wollaston DE Xu X Tokumaru O Chen JD McNearney TA Patients with systemic sclerosis have unique and persistent alterations in gastric myoelectrical activity with acupressure to Neiguan Point PC6 J Rheumatol 2005 32 494 501
98. Bortolotti M Bolondi L Santi V Sarti P Brunelli F Barbara L Patterns of gastric emptying in dysmotility-like dyspepsia Scand J Gastroenterol 1995 30 408 10
99. Chen J McCallum RW eds Electrogastrography - Principles and Applications New York, USA Raven 1995
100. Chen J Schirmer BD McCallum RW Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis Am J Physiol 1994 266 G90 8
101. Wang ZS Elsenbruch S Orr WC Chen JD Detection of gastric slow wave uncoupling from multi-channel electrogastrogram: validations and applications Neurogastroenterol Motil 2003 15 457 65
102. Chen JDZ Lin ZY McCallum RW Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis Dig Dis Sci 1996 41 1538 45
103. Soykan I Lin Z Sarosiek I McCallum RW Gastric myoelectrical activity, gastric emptying, and correlations with symptoms and fasting blood glucose levels in diabetic patients Am J Med Sci 1999 317 226 31
104. Pfaffenbach B Wegener M Adamek RJ et al. Antral myoelectrical activity, gastric emptying and dyspeptic symptoms in diabetics Scand J Gastroenterol 1995 30 1166 71
105. Jebbink HJ Bruijs PP Bravenboer B Akkermans LM van Berge-Henegouwen GP Smout AJ Gastric myoelectrical activity in patients with type I diabetes mellitus and autonomic neuropathy Dig Dis Sci 1994 39 2376 83
106. McNearney T Lin X Shrestha J Lisse J Chen JD Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography Dig Dis Sci 2002 47 690 8
107. Satake K Hongo M Ujiie H Okuno Y Toyota T Lin YF Esophageal motility and gastric emptying in SSC patients, correlation with symptoms Nippon Shokakibyo Gakkai Zasshi 1990 87 1629 35
108. Jonderko G Golab T Kucharz E et al. Influence of progressive systemic sclerosis on gastric emptying Pol Arch Med Wewn 1993 90 13 8
109. Wedmann B Wegener M Adamek RJ el Gammal S Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis. A sonographic study Dig Dis Sci 1994 39 565 70
110. Pfaffenbach B Adamek RJ Hagemann D et al. Effect of progressive systemic sclerosis on antral myoelectrical activity and gastric emptying Z Gastroenterol 1996 34 517 21
111. Kikuchi K Kusano M Kawamura O Mori M Sekiguchi T Measurement and evaluation of gastric emptying using radiopaque barium markers Dig Dis Sci 2000 45 242 7
112. Madsen JL Hendel L Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis Dig Dis Sci 1992 37 1404 8
113. Mo J Wang C Wang S Gastric emptying and intragastric distribution of liquid and solid meal in patients with systemic sclerosis Zhonghua Nei Ke Za Zhi 1996 35 530 2
114. Soykan I Sarosiek I Shifflett J Wooten GF McCallum RW Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease Mov Disord 1997 12 952 7
115. Koch Kl Stern RM Stewart WR et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment Am J Gastroenterol 1989 84 1069 75
116. Rees WD Leigh RJ Christofides ND Bloom SR Turnberg LA lnterdigestive motor activity in patients with systemic sclerosis Gastroenterology 1982 83 575 80
117. Lazzara R Stoudemire A Manning D Prewitt K Metoclopramide-induced tardive dyskinesia: a case report Gen Hosp Psychiatry 1986 8 107 9
118. Robinson D Omar S Dangel C Fenn H Tinklengerg J Metoclopramide-induced extra pyramidal symptoms in a diabetic patient J Am Geriatr Soc 1994 42 1307 8
119. Tung A Sweitzer B Cutter T Cardiac arrest after labetalol and metoclopramide administration in a patient with scleroderma Anesth Analg 2002 95 1667 8
120. Kahan A Chaussade S Gaudric M et al. The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study Br J Clin Pharmacol 1991 31 683 7
121. Janssens J Peeters TL Vantrappen G et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies N Engl J Med 1990 322 1028 31
122. Fiorucci S Distrufti V Gerli R Morelli A Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term Am J Gastroenterol 1994 89 550 5
123. Folwaczny C Laritz M Meurer M Endres SP Konig A Schindibeck N Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma Z Gastroenterol 1997 35 905 12
124. Verne GN Eaker EY Hardy E Sninsky CA Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudo-obstruction Dig Dis Sci 1995 40 1892 901
125. Tack J Vos R Janssens J Salter J Jauffret S Vandeplassche G Influence of tegaserod on proximal gastric tone and on the perception of gastric distension Aliment Pharmacol Ther 2003 18 1031 7
126. Degen L Matzinger D Merz M et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects Aliment Pharmacol Ther 2001 15 1745 51
127. Prather CM Camilleri M Zinsmeister AR McKinzie S Thomforde G Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome Gastroenterology 2000 118 463 8
128. Tougas G Chen Y Luo D et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms Gastroenterology 2003 (abstract ID 107715)
129. Edmunds MC Chen JD Soykan I Lin Z McCallum RW Effect of octreotide on gastric and small bowel motility in patients with gastroparesis Aliment Pharmacol Ther 1998 12 167 74
130. McCallum R Lin Z Wetzel P Sarosiek I Forster J Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis Clin Gastroenterol Hepatol 2005 3 49 54
131. Barker MCJ Cobden I Axon ATR Proximal stomach and antrum in stomach emptying Gut 1979 20 309
132. Jouanolle H Bretagne JF Ramee MP et al. Antral vascular ectasia and scleroderma. Endoscopic, radiologic and anatomopathologic aspects of an uncommon association Gastroenterol Clin Biol 1989 13 217 21
133. Gimmon Z Katz S Eyal Z Surgical aspects of multifocal involvement of the gastrointestinal tract in progressive systemic sclerosis Int Surg 1982 67 Suppl. 4 471 3
134. Lin ZY McCallum RW Schirmer BD Chen JDZ Effects of pacing parameters in the entrainment of gastric slow waves in patients with gastroparesis Am J Physiol Gastrointest Liver Physiol 1998 37 G186 91
135. Abell T McCallum R Hocking M Gastric electrical stimulation for medically refractory gastroparesis Gastroenterology 2003 125 421 8
136. Chang CS Ko CW Wu CY Chen GH Effect of electrical stimulation on acupuncture points in diabetic patients with gastric dysrhythmia: a pilot study Digestion 2001 64 184 90
137. Murphy PA Alternative therapies for nausea and vomiting of pregnancy Obstet Gynecol 1998 91 149 55
138. Roscoe JA Matteson SE Acupressure and acustimulation bands for control of nausea: a brief review Am J Obstet Gynecol 2002 185 Suppl. S244 7
139. Hu S Stern RM Koch KL Electrical acustimulation relieves vection-induced motion sickness Gastroenterology 1992 102 1854 8
140. Lin X Liang J Ren J Mu F Chen JDZ Electrical stimulation of acupuncture points enhances gastric myoelectrical activity in humans Am J Gastroenterol 1997 92 1527 30
141. Shiotani A Tatewaki M Hoshino E Takahashi T Effects of electroacupuncture on gastric myoelectrical activity in healthy humans Neurogastroenterol Motil 2004 16 293 8
142. Chang CS Cutaneous electrical stimulation of acupuncture points may enhance gastric myoelectrical regularity Digestion 2002 66 106 11
143. Xu S Zha H Hou X Chen JDZ Electroacupuncture accelerates solid gastric empting in patients with functional dyspepsia Gastroenterology 2004 126 T1163 (abstract)
144. Ouyang H Yin J Wang Z Pasricha PJ Chen JD Electroacupuncture accelerates gastric emptying in association with changes in vagal activity Am J Physiol 2002 282 G390 6
145. Ouyang H Yin J Chen JDZ Transcutaneous electrical stimulation of acupuncture points increases vagal activity in healthy humans Neurogastroenterol Motil 2000 12 490 (abstract)
146. Sallam H Doshi D McNearney T Chen JDZ Transcutaneous electrical nerve stimulation improves gastric motility, dyspeptic symptoms and physical functioning in patients with systemic sclerosis by balancing the sympathovagal activity Gastroenterology 2005 A-468 T1155 (abstract)
147. Han JS Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies Trends Neurosci 2003 26 17 22
148. Marie I Levesque H Ducrotte P Courtois H Atteinte de l'intestin grêle au cours de la sclerodermie systematique In Mise au point - maladies orphelines Rev Med Interne Paris Elsevier 1999 20 504 13
149. Gough A Andrews D Bacon PA Emery P Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma Br J Rheumatol 1995 34 976 7
150. Ebert EC Ruggiero FM Seibold JR Intestinal perforation. A common complication of scleroderma Dig Dis Sci 1997 42 549 53
151. Quiroz ES Flannery MT Martinez EJ Warner EA Pneumatosis cystoids intestinalis in progressive systemic sclerosis: a case report and literature review Am J Med Sci 1995 310 252 5
152. You CH Chey WY Lee KY Menguy R Bortoff A Gastric and small intestinal myoelectrical dysrhythmia associated with chronic intractable nausea and vomiting Ann Int Med 1981 95 449 51
153. Vantrappen G Janssens J Hellemans J et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine J Clin Invest 1977 59 1158
154. Soudah HC Haasler Wl Owyang C Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma N Engl J Med 1991 325 1461
155. Caserta L De Magistris L Secondulfo M et al. Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters Rheumatol Int 2003 23 226 30
156. Battle WM Snape WJ Jr. Wright S et al. Abnormal colonic motility in progressive systemic sclerosis Ann Intern Med 1981 94 749 52
157. Scutellari PN Cinofti A Orzincolo C et al. Changes in the small and large intestines in systemic sclerosis Radiol Med (Torino) 1990 80 876 81
158. Davis RP Hines JR Flinn WR Scleroderma of the colon with obstruction: report of a case Dis Colon Rectum 1976 19 256 9
159. Sacher P Buchmann P Burger H Stenosis of the large intestine complicating scleroderma and mimicking a sigmoid carcinoma Dis Colon Rectum 1983 26 347 8
160. Snape WJ Jr. Myoelectric and motor activity of the colon in normal and abnormal states Scand J Gastroenterol Suppl 1984 96 55 60
161. Wang SJ Lan JL Chen DY Chen YH Hsieh TY Lin WY Colonic transit disorders in systemic sclerosis Clin Rheumatol 2001 20 251 4
162. Whitehead WE Taitelbaum G Wigley FM Schuster MM Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis Gastroenterology 1989 96 2 Pt 1 428 32
163. Folwaczny C Rothfuss U Riepi RL et al. Gastrointestinal involvement in progressive systemic scleroderma Z Gastroenterol 1995 33 654 61
164. Basilisco G Barbera R Vanoli M Bianchi P Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis Dig Dis Sci 1993 38 1525 9
165. Folwaczny C Voderholzer W Riepi RL Schindlbeck N Clinical aspects, pathophysiology, diagnosis and therapy of gastrointestinal manifestations of progressive systemic scleroderma Z Gastroenterol 1996 34 497 508
166. Stafford-Brady FJ Kahn HJ Ross TM Russell ML Advanced scleroderma bowel: complications and management Rheumatology 1988 15 869 74
167. Panganamamula KV Parkman HP Chronic intestinal pseudo-obstruction Curr Treat Options Gastroenterol 2005 8 3 11
168. Pavlovic M Saiag P Lotz JP Marinho E Clerici T Izrael V Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide Arch Dermatol 1995 131 1207 9
169. Wang SJ Lan JL Lan JL et al. Effects of cisapride on colonic transit in patients with progressive systemic sclerosis Clin Rheumatol 2002 21 271 4
170. Boeckxstaens GE Bartelsman JF Lauwers L Tytgat GN Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride Am J Gastroenterol 2002 97 194 7
171. Perlemuter G Cacoub P Chaussade S Wechsler B Couturier D Piette JC Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases Arthritis Rheum 1999 42 1545 9
172. Kobayashi T Kobayashi M Naka M Nakajima K Momose A Toi M Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis Intern Med 1993 32 607 9
173. Descamps V Duval X Crickx B Bouscarat F Coffin B Belaich S Global improvement of systemic scleroderma under long-term administration of octreotide Eur J Dermatol 1999 9 446 8
174. Lecomte T Cavicchi M Delchier JC Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin Gastroenterol Clin Biol 2000 24 361 3
175. Lindsey I Farmer CR Cunningham IG Subtotal colectomy and cecosigmoid anastomosis for colonic systemic sclerosis: report of a case and review of the literature Dis Colon Rectum 2003 46 1706 11
176. Lin X Hayes J Peters LJ Chen JD Entrainment of intestinal slow waves with electrical stimulation using intraluminal electrodes Ann Biomed Eng 2000 28 582 7
177. Lin X Peters LJ Hayes J Chen JD Entrainment of segmental small intestinal slow waves with electrical stimulation in dogs Dig Dis Sci 2000 45 652 6
178. Abo M Liang J Qian L Chen JD Distension-induced myoelectrical dysrhythmia and effect of intestinal pacing in dogs Dig Dis Sci 2000 45 129 35
179. Chen JDZ Lin HC Electrical pacing accelerates intestinal transit slowed by fat-induced ileal brake Dig Dis Sci 2003 48 251 6
180. Shafik A Shafik AA El-Sibai O Ahmed I Colonic pacing: a therapeutic option for the treatment of constipation due to total colonic inertia Arch Surg 2004 139 775 9
181. Tabosa A Yamamura Y Forno ER Mello LE Effect of the acupoints ST-36 (Zusanli) and SP-6 (Sanyinjiao) on intestinal myoelectric activity of Wistar rats Braz J Med Biol Res 2002 35 731 9
182. Choi M Jung J Seo M et al. Ultrasonographic observation of intestinal mobility of dogs after acupunctural stimulation on acupoints ST-36 and BL-27 J Vet Sci 2001 2 221 6
183. Leighton JA Valdovinos MA Pemberton JH Rath DM Camilleri M Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis Dis Colon Rectum 1993 36 182 5
184. D'Angelo G Stern HC Myers E Rectal prolapse in scleroderma: case report and review of the colonic complications of scleroderma Can J Surg 1985 28 62
185. Jaffin BW Chang P Spiera H Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications J Clin Gastroenterol 1997 25 513 7
186. Massone C Milone L Parodi A Pandolfo N Rebora A Anorectal involvement is frequent in limited systemic sclerosis Acta Derm Venereol 2002 82 446 8
187. Herrick AL Barlow JD Bowden A et al. Investigation of anal function in patients with systemic sclerosis Ann Rheum Dis 1996 55 370 4
188. Chiou AW Lin JK Wang FM Anorectal abnormalities in progressive systemic sclerosis Dis Colon Rectum 1989 32 417 21
189. Hamel-Roy J Devroede G Arhan P Tetreault L Duranceau A Menard H Comparative esophageal and anorectal motility in scleroderma Gastroenterology 1985 88 1 7
190. Heyt GJ Oh MK Alemzadeh N et al. Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence Dig Dis Sci 2004 49 1040 5
191. Kim KC Park HJ Lee SK et al. Anorectal dysfunction in systemic sclerosis J Korean Med Sci 1996 1 244 9
192. Frieling T Enck P Bremer G Lubke HJ Berges W Wienbeck M Anorectal
193. Kenefick NJ Vaizey CJ Nicholls RJ Cohen R Kamm MA Sacral nerve stimulation for faecal incontinence due to systemic sclerosis Gut 2002 51 881 3
194. Broide E Pintov S Portnoy S Barg J Klinowski E Scapa E Effectiveness of acupuncture for treatment of childhood constipation Dig Dis Sci 2001 46 1270 5
195. Klauser AG Rubach A Bertsche O Muller-Lissner SA Body acupuncture: effect on colonic function in chronic constipation Z Gastroenterol 1993 31 605 8
196. Olive A Maddison PJ Davis M Treatment of oesophagitis in scleroderma with omeprazole Br J Rheumatol 1989 28 553
197. Hendel L Hydroxyproline in the oesophageal mucosa of pts with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis Aliment Pharmacol Ther 1991 5 471 80
198. Hostein J Li V Carpentier P Fournet J Omeprazole: crucial progress in the treatment of esophagitis in progressive systemic scleroderma Gastroenterol Clin Biol 1991 15 460 1
199. Kundrotas L Ward RW Omeprazole vs ranitidine in pts with progressive systemic sclerosis and symptomatic esophagitis (abstract 34) Am J Gastroenterol 1992 87 1250
200. Hendel L Hage E Hendel J et al. Therapeutic monitoring of omeprazole treatment of gastro-oesophageal reflux disease (abstract) Gastroenterology 1993 104 Suppl. A99
201. Hage E Hendel L Gustafsen J Hendel J Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole Eur J Gastroenterol Hepatol 2003 15 781 9
202. Nishioka T Sekiguchi T Machida M et al. Effects of cisapride on lower esophageal sphincter pressure and gastroduodenal motor activity in man Nippon Heikatsukin Gakkai Zasshi 1986 22 103 12
203. Horowitz M Maddern GJ Maddox A Wishart J Chatterton BE Shearman DJ Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis Gastroenterology 1987 93 311 5
204. Linke R Meier M Muenzing W Folwaczny C Schnell O Tatsch K Prokinetic therapy: what can be measured by gastric scintigraphy Nucl Med Commun 2005 26 527 33